000 | 01044 a2200289 4500 | ||
---|---|---|---|
005 | 20250514042140.0 | ||
264 | 0 | _c20020905 | |
008 | 200209s 0 0 eng d | ||
022 | _a1551-8396 | ||
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aChaisson, R E | |
245 | 0 | 0 |
_aOpportunistic infections. _h[electronic resource] |
260 |
_bThe Hopkins HIV report : a bimonthly newsletter for healthcare providers _cSep 2000 |
||
300 |
_a10, 16 p. _bdigital |
||
500 | _aPublication Type: Congress; Newspaper Article | ||
650 | 0 | 4 |
_aAIDS-Related Opportunistic Infections _xdrug therapy |
650 | 0 | 4 | _aAntiretroviral Therapy, Highly Active |
650 | 0 | 4 | _aDrug Therapy, Combination |
650 | 0 | 4 | _aHumans |
650 | 0 | 4 |
_aIsoniazid _xtherapeutic use |
650 | 0 | 4 |
_aRifabutin _xadministration & dosage |
650 | 0 | 4 | _aSouth Africa |
650 | 0 | 4 | _aToxoplasmosis |
650 | 0 | 4 |
_aTuberculosis _xdrug therapy |
700 | 1 | _aSterling, T R | |
773 | 0 |
_tThe Hopkins HIV report : a bimonthly newsletter for healthcare providers _gvol. 12 _gno. 4 _gp. 10, 16 |
|
999 |
_c12066633 _d12066633 |